ProKidney Corp. (PROK) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts PROK Hot Sheet
Join SI Premium – FREE
ProKidney Corp. (NASDAQ: PROK) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).
For earnings history and earnings-related data on ProKidney Corp. (PROK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
